Digital Scoop IndiaRevolutionizing Healthcare Accessibility: Arogya Aushadhi’s Mission to Provide Affordable MedicinesIn a bold move that promises to reshape the landscape of healthcare in India, Cuatrocare Lifescience Pvt Ltd has introduced Arogya…Jun 20
Crowd Funded CuresHow to Solve The Tragedy of the Commons Caused by Reliance on the Patent System to Develop New…The Problem: Lack of Private Incentives to Repurpose Off-Patent DrugsNov 16, 2021
Crowd Funded CuresUsing Social Impact Bonds in the Quest for Accessible and Affordable Open Source MedicinesFollowing on from the Global Financial Crisis (GFC), governments around the world have been looking for innovative ways to make a bigger…Jul 5, 2021Jul 5, 2021
Raj S DattaniA response to the JAMA Drug Pricing special issueThis Letter to the Editor was composed by Peter Kolchinsky, Mark Charbonneau and myself during the Spring 2020 “Business in Biotechnology”…Apr 6, 2020Apr 6, 2020
InPharmacyCheckerbyGabriel LevittNewly Approved Generic Drugs: Cost and Lack of Availability in the United StatesFaster generic drug approvals are often looked to as a key part of the solution to high drug prices. Yet FDA approval of a generic neither…Jul 19, 2019Jul 19, 2019
Digital Scoop IndiaRevolutionizing Healthcare Accessibility: Arogya Aushadhi’s Mission to Provide Affordable MedicinesIn a bold move that promises to reshape the landscape of healthcare in India, Cuatrocare Lifescience Pvt Ltd has introduced Arogya…Jun 20
Crowd Funded CuresHow to Solve The Tragedy of the Commons Caused by Reliance on the Patent System to Develop New…The Problem: Lack of Private Incentives to Repurpose Off-Patent DrugsNov 16, 2021
Crowd Funded CuresUsing Social Impact Bonds in the Quest for Accessible and Affordable Open Source MedicinesFollowing on from the Global Financial Crisis (GFC), governments around the world have been looking for innovative ways to make a bigger…Jul 5, 2021
Raj S DattaniA response to the JAMA Drug Pricing special issueThis Letter to the Editor was composed by Peter Kolchinsky, Mark Charbonneau and myself during the Spring 2020 “Business in Biotechnology”…Apr 6, 2020
InPharmacyCheckerbyGabriel LevittNewly Approved Generic Drugs: Cost and Lack of Availability in the United StatesFaster generic drug approvals are often looked to as a key part of the solution to high drug prices. Yet FDA approval of a generic neither…Jul 19, 2019
InTrueMDbyAayush JainLet me show you a magic trick..Today, I am going to show you a magic trick. Grab your popcorn and drinks!Sep 10, 20164
InTrueMDbyAdi JoshiTrueMD: The Story Continues…For all those who remember TrueMD — Awesome!Sep 9, 2016
